Market Overview:
Biomarkers are defined as biological measures of a biological state. It is an indicator of normal biological processes, pharmacological responses or pathogenic processes for therapeutic intervention.
The global biomarkers market Growth, during the forecast period 2019 to 2027, will register growth at a CAGR of 10.28%. The market for biomarkers is set to reach US$4,582.8 million income by 2027.
Biomarkers are clinical measures for assessment such as blood pressure or cholesterol level and help in monitoring and predicting health status in individuals as well as in populations which promotes planning of appropriate therapeutic intervention. Biomarkers are used to predict serious illnesses such as diabetes and cardiovascular disease. Each individual biomarker indicates whether there is a disease or health state and can be combined to provide a detailed picture of how healthy a person is and whether or not a diagnosis needs to be made. Biomarkers have proved to be especially helpful in cancer research as certain DNA or RNA markers may therefore help in the detection and treatment of specific cancers.
Market Segmentation:
The biomarkers market size has been segmented into disease indication, application, type, and product. Based on the segment, which is disease indications, the market is categorized on the basis of cancer, cardiovascular disorders, immunological disorders, neurological disorders, and others. The global market for biomarkers is further segmented based on application into diagnostics, disease risk assessment, drug discovery and development, and personalized medicine. Furthermore, the market, on the basis of type, is segmented into efficacy biomarkers, safety biomarkers, and validation biomarkers. Based on the segment, which is product, the market is categorized on the basis of consumables, services, and software.
The global market research report covers all the aspects of the market based on the segmental analysis of these disease indications, application, type, and product segments. Analysts have also studied the global market's regional markets spread across many continents and countries. The disease indication, application, type, and product segments along with their sub-segments have been analyzed and companies functioning in the market across these segments are profiled and analyzed based on input and feedback from market-based decision makers as well as primary and secondary sources. The biomarkers market research report presents analysis-based information for companies functioning in the market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1941
Regional Overview:
The spike in cancer cases globally may hinder the market growth. The market research report suggests that companies in the market could be supported by the spike in cancer cases globally as well as increasing applications and advancements of biomarkers during the forecast period. The market is set to register growth at a high CAGR owing to these key factors. The biomarkers market is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global market research report reveals that APAC, North
America, and Europe regional markets will dominate the global market for biomarkers during the forecast period 2019 to 2027. As per market analysts, the market is set to witness tremendous growth across consumables and safety biomarkers segments in North America which covers markets across the United States, Canada, Mexico and several other regional markets. Companies active in the market are also analyzed and studied in the market research report.
The market for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the market research report covers the Asia-Pacific region covering markets from India, China, Japan, Australia, and others. The biomarkers market is also spread across the rest of the world. The market report covers all such regions including the Middle East, Africa, Brazil, and others.
Competitive Landscape:
- Qiagen N.V.,
- Thermo Fisher Scientific Inc.,
- Hoffmann-La Roche Ltd,
- PerkinElmer Inc.,
- Merck KGaA,
- Bio-Rad Laboratories,
- Abbott Laboratories,
- EKF Diagnostics,
- Enzo Biochem Inc.,
- Meso Scale Diagnostics, LLC,
- Signosis
- PerkinElmer Inc.
Industry News:
Medidata, a life science technology and clinical trial data firm, reported today that it has acquired the automated biomarker business of sensor manufacturer MC10. The deal's terms were kept under wraps. The acquisition would enable Medidata (a subsidiary of Dassault Systems) to incorporate biometric data and new analytics tools to its Patient Cloud platform, which will support patient-reported results, clinical outcome evaluations, and novel biomarker discovery, according to the company. Meanwhile, large corporations such as Johnson & Johnson and LabCorp have made significant efforts within their divisions to make remote clinical trial designs more feasible.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/biomarker-market-1941
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
